Presentation TVT 2017 Featured Lecture: The Use of TAVR for Bioprosthetic Aortic Valve Failure - Only for High-Risk Surgical Patients or an Integral Component of AS Management Strategies Presenter: Albert Markus Kasel, Thomas Walther June 15, 2017
Presentation TVT 2017 A Surgeon/Interventionalists Perspectives of Transcatheter Mitral and Tricuspid Valve Therapies Evolution, Impact, and Future Expectations Presenter: Mark Reisman, Gregg W. Stone, Francesco Maisano June 15, 2017
Presentation TVT 2017 Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference? Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy June 15, 2017
Presentation TVT 2017 TAVR in Perspective Evolution, Impact, and Future Expectations Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon June 15, 2017
Presentation TVT 2017 Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow June 15, 2017
Presentation TVT 2017 4C Valve: A Novel Transcatheter MR Treatment Technology Presenter: Juan F. Granada, Martin B. Leon, Gregg W. Stone, Philippe Généreux June 14, 2017
Presentation TVT 2017 Early Preclinical Experience of Aortic Valve-In-Ring Procedure Presenter: Juan F. Granada, Martin B. Leon, Gregg W. Stone, Martin Andreas, MD June 14, 2017
Presentation TVT 2017 The Corona Mitral Valve Replacement System: An Innovative Modular Solution to Mitral Regurgitation Presenter: Juan F. Granada, Martin B. Leon, Gregg W. Stone, David Meerkin, MD June 14, 2017
Presentation TVT 2017 Fully Absorbable Patch-Based Large Hole Vascular Closure Device - EU Multi-center Clinical Experience Presenter: Juan F. Granada, Martin B. Leon, Gregg W. Stone, Michael Laule, MD June 14, 2017